Duesseldorf, Jarmalka, ayaa isu diyaarinaysa kobcinta dadka Maraykanka ah ee cayilan iyagoo raadinaya warqad dhakhtar Ozempic ah oo ay la socoto baaritaan caafimaad oo la awoodi karo laakiin ugu sarreeya, inta badan lagama heli karo Maraykanka sababtoo ah caymiska Maraykanku ma daboolayo.
Soo-booqdayaasha Dusseldorf uma baahna inay ka werweraan cabbitaanka bir "alt" yar ama ku raaxaysan "Sauerbraten" (dubay dhanaan). Sahayda hal bil ah ee Ozempic waxay Jarmalka ku iibisaa wax ka yar $77.00 caymis la'aan.
Kuwa ku jira Medicaid ama Medicare, Ozempic waxa laga yaabaa in dhawaan caymisku daboolo, si ay guriga u joogaan. Isla mar ahaantaana, waxay ku kacaysaa canshuur bixiyeyaasha Mareykanka $35 Billion tobannaanka soo socda si ay u sameeyaan daawooyinka sida Ozempic, Wegovy, iyo Zepbound ay heli karaan dadka Mareykanka ah ee buuran ee ku jira Medicare iyo Medicaid.
Qiimaha 28-maalmood ee sahayda daawadani waxay u dhaxaysaa $850.00 ilaa $1600.00 bishiiba gudaha Maraykanka kuwa aan lahayn caymis.
Bukaanku wuxuu u baahan doonaa inuu isku duro toddobaad kasta. Hal baakidh oo lagu iibiyo Maraykanka ayaa leh afar irbadood iyo hal qalin oo ku habboon afar toddobaad.
Novo Nordisk, oo ah shirkadda Danishka ee soo saarta dawadan, ayaa ciyaareysa ciyaar wasakh ah. Qaabka ganacsigeeda ayaa ah in ay balaayiin ka faa'iidaysato macaamiisha Maraykanka iyada oo dawada siinaysa reer Yurub qiimo cadaalad ah.
eTurboNews ayaa uga digay akhristeyaasheeda khiyaamo nafta halis gelisa oo ku lug leh Ozempic dhawr toddobaad ka hor. Horumarkani wuu ka duwan yahay maadaama Ozempic lagu iibiyo Jarmalka uu la mid yahay kan Maraykanka oo uu iibiyo isla saaraha.
"Waa maalin u wanaagsan qof kasta oo la ildaran cayilka," Xoghayaha Caafimaadka iyo Adeegyada Aadanaha ee Maraykanka Xavier Becerra ayaa u sheegay Associated Press, isagoo ka faalloonaya in dawadan laga yaabo inay daboolaan Medicare iyo Medicaid si ay u cayilaan Maraykanka dhawaan. "Waxay u tahay ciyaarta beddelka dadka Maraykanka ah ee aan awoodin inay iska bixiyaan dawooyinkan haddii kale."
In kasta oo sharciga cusub ee Biden uu soo jeediyay lagu bogaadin karo caawinta dadka buuran ee Mareykanka ah inay galaan dawadan, waxay u muuqataa in qofna uusan su'aal ka gelin qiimaha. Novo Nordisk waxay jeebka ku shuban kartaa faa'iidada maskaxda ku haysa iyada oo aan la baadhin iyada oo ka iibinaysa Ozempic dadka Maraykanka ah waxayna haysataa cashuur bixiyaha Maraykanka oo daboolaya kharashka.
Waa kan xaqiiqadu. Halka sahayda hal bil ah ee dawadan ay si fudud ugu iibinayso $1,000.00 kuwa aan caymis ku lahayn Maraykanka, qiimaha isla dawadan ee Jarmalka oo aan caymis lahayn ayaa ka yar $77.00.
Farqiga kaliya ee Jarmalka ayaa ah in Ozempic lagu iibiyo sahayda 12-usbuuc ah oo leh saddex saddex qalin iyo 12 irbadood oo ah EURO 216.70 ama $228.47, taasoo ka dhigaysa $76.16 bishii.
Kuwa leh caymiska caafimaadka ee Jarmalka, wada-bixintu waa EURO 10.00 ama $10.55
Si loo caddeeyo, iibsashada sahayda Ozempic ee Maraykanka ee saddexda bilood ah waxay ku kacaysaa in ka badan $ 3,000.00, halka isla sahayda Jarmalka ee daawada Ozempic lagu iibiyo $ 228.47. Tani waxay ka badan tahay 90% faraqa qiimaha, taasoo shirkadda Novo Nordisk, oo ah shirkadda dawooyinka deenishka, ay ku dallaci karto dadka Maraykanka ah isla badeecada.
Goorma eTurboNews Waxaan la xiriirnay Novo Nordisk, ma jirin wax jawaab ah. Markaad la hadlayso farmashiistaha Jarmalka ee ka socda Cologne, eTurboNews ayaa loo sheegay in dawada mararka qaarkood ay adag tahay in la helo. Waxay u muuqataa in qaybinta Maraykanka ay tahay mudnaanta, taas oo aan la yaab lahayn marka la baranayo 90+% farqiga qiimaha.
Maamulka Trump ee imanaya ayaa laga yaabaa inuu joojiyo sharcigan, laakiin kuwa khasaaray ayaa hubaal ah inay noqon doonaan kuwa Maraykanka ah ee u baahan dawada oo aan awoodin.
